NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Go back to NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.12 -0.46 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.58 | 52 Week High | $77.12 | |||
| Open | $58.88 | 52 Week Low | $49.03 | |||
| Day High | $59.79 | P/E | 38.39 | |||
| Day Low | $58.74 | EPS | $1.54 | |||
| Volume | 9,253,469 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 151.17 +4.07 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.10 | 52 Week High | $108.63 | |||
| Open | $147.23 | 52 Week Low | $71.39 | |||
| Day High | $151.44 | P/E | 83.52 | |||
| Day Low | $146.10 | EPS | $1.81 | |||
| Volume | 5,802,173 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 510.08 +6.83 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $503.25 | 52 Week High | $134.71 | |||
| Open | $502.11 | 52 Week Low | $73.31 | |||
| Day High | $514.90 | P/E | N/A | |||
| Day Low | $502.06 | EPS | $-1.98 | |||
| Volume | 1,480,853 | |||||



